Literature DB >> 15239668

RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Ester Piek1, Maarten Van Dinther, W Tony Parks, John M Sallee, Erwin P Böttinger, Anita B Roberts, Peter Ten Dijke.   

Abstract

We have described previously the use of microarray technology to identify novel target genes of TGF-beta (transforming growth factor-beta) signalling in mouse embryo fibroblasts deficient in Smad2 or Smad3 [Yang, Piek, Zavadil, Liang, Xie, Heyer, Pavlidis, Kucherlapati, Roberts and Böttinger (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 10269-10274]. Among the TGF-beta target genes identified, a novel gene with sequence homology to members of the Ras superfamily was identified, which we have designated as RLP (Ras-like protein). RLP is a Smad3-dependent immediate-early TGF-beta target gene, its expression being induced within 45 min. Bone morphogenetic proteins also induce expression of RLP, whereas epidermal growth factor and phorbol ester PMA suppress TGF-beta-induced expression of RLP. Northern-blot analysis revealed that RLP was strongly expressed in heart, brain and kidney, and below the detection level in spleen and skeletal muscles. At the protein level, RLP is approx. 30% homologous with members of the Ras superfamily, particularly in domains characteristic for small GTPases. However, compared with prototypic Ras, RLP contains a modified P-loop, lacks the consensus G2 loop and the C-terminal prenylation site and harbours amino acid substitutions at positions that render prototypic Ras oncogenic. However, RLP does not have transforming activity, does not affect phosphorylation of mitogen-activated protein kinase and is unable to bind GTP or GDP. RLP was found to associate with certain subtypes of the TGF-beta receptor family, raising the possibility that RLP plays a role in TGF-beta signal transduction. Although RLP did not interact with Smads and did not affect TGF-beta receptor-induced Smad2 phosphorylation, it inhibited TGF-beta-induced transcriptional reporter activation, suggesting that it is a novel negative regulator of TGF-beta signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239668      PMCID: PMC1134058          DOI: 10.1042/BJ20040774

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Specificity, diversity, and regulation in TGF-beta superfamily signaling.

Authors:  E Piek; C H Heldin; P Ten Dijke
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

Review 2.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

3.  Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases.

Authors:  W T Parks; D B Frank; C Huff; C Renfrew Haft; J Martin; X Meng; M P de Caestecker; J G McNally; A Reddi; S I Taylor; A B Roberts; T Wang; R J Lechleider
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

4.  Rem2, a new member of the Rem/Rad/Gem/Kir family of Ras-related GTPases.

Authors:  B S Finlin; H Shao; K Kadono-Okuda; N Guo; D A Andres
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 5.  The Ras branch of small GTPases: Ras family members don't fall far from the tree.

Authors:  G W Reuther; C J Der
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

6.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.

Authors:  J Zavadil; M Bitzer; D Liang; Y C Yang; A Massimi; S Kneitz; E Piek; E P Bottinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

7.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

8.  Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.

Authors:  J Yue; K M Mulder
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

9.  Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.

Authors:  H Hanafusa; J Ninomiya-Tsuji; N Masuyama; M Nishita; J Fujisawa; H Shibuya; K Matsumoto; E Nishida
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

10.  Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.

Authors:  P Laine; N Reunanen; L Ravanti; M Foschi; M Santra; R V Iozzo; V M Kähäri
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

View more
  6 in total

1.  Chromatin association and regulation of rDNA transcription by the Ras-family protein RasL11a.

Authors:  Mariaelena Pistoni; Alessandro Verrecchia; Mirko Doni; Ernesto Guccione; Bruno Amati
Journal:  EMBO J       Date:  2010-02-18       Impact factor: 11.598

2.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

3.  Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons.

Authors:  Ignacio Lopez-Coviella; Maximillian T Follettie; Tiffany J Mellott; Vesela P Kovacheva; Barbara E Slack; Veronica Diesl; Brygida Berse; R Scott Thies; Jan Krzysztof Blusztajn
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

4.  Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation.

Authors:  Marie-Hélène Blanchet; J Ann Le Good; Daniel Mesnard; Viola Oorschot; Stéphane Baflast; Gabriella Minchiotti; Judith Klumperman; Daniel B Constam
Journal:  EMBO J       Date:  2008-09-04       Impact factor: 11.598

5.  Effects of activin and TGFβ on p21 in colon cancer.

Authors:  Jessica Bauer; Judith C Sporn; Jennifer Cabral; Jessica Gomez; Barbara Jung
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

6.  Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.

Authors:  Jessica Bauer; Ozkan Ozden; Naomi Akagi; Timothy Carroll; Daniel R Principe; Jonas J Staudacher; Martina E Spehlmann; Lars Eckmann; Paul J Grippo; Barbara Jung
Journal:  Mol Cancer       Date:  2015-10-24       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.